Clinical Trials
- Brain, Spinal Cord & Nervous System
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis (CONSONANCE)
- Ages18 years - 65 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
CELLO Study for Radiologically Isolated Syndrome (RIS)
- Ages18 years - 40 years
- GenderBoth
- Brain, Spinal Cord & Nervous System
Cognitive Training Study in Parkinson’s Disease
- COVID-19 Vaccine
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
Evaluating the Immune Response to COVID-19 Vaccination in B-cell Depleted Patients
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System, HIV/AIDS, Infectious Disease, COVID-19 Inpatient, COVID-19 Outpatient
HIV Associated Reservoirs and Comorbidities (The HARC Plus Study)
- Brain, Spinal Cord & Nervous System
Multiple Sclerosis: Symptoms and Hormones Study
- Ages18 years - 45 years
- GenderFemale only
- COVID-19 Inpatient, COVID-19 Outpatient
Patient response to COVID19 outbreak
- Ages18 years and older
- GenderBoth
- Brain, Spinal Cord & Nervous System
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH)
- Ages18 years and older
- GenderBoth